ZA765331B - Novel pharmaceutically active compounds - Google Patents

Novel pharmaceutically active compounds

Info

Publication number
ZA765331B
ZA765331B ZA765331A ZA765331A ZA765331B ZA 765331 B ZA765331 B ZA 765331B ZA 765331 A ZA765331 A ZA 765331A ZA 765331 A ZA765331 A ZA 765331A ZA 765331 B ZA765331 B ZA 765331B
Authority
ZA
South Africa
Prior art keywords
active compounds
pharmaceutically active
novel pharmaceutically
novel
compounds
Prior art date
Application number
ZA765331A
Other languages
English (en)
Inventor
L Svensson
L Sorenby
K Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ZA765331B publication Critical patent/ZA765331B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA765331A 1975-10-01 1976-09-07 Novel pharmaceutically active compounds ZA765331B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
ZA765331B true ZA765331B (en) 1977-08-31

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA765331A ZA765331B (en) 1975-10-01 1976-09-07 Novel pharmaceutically active compounds

Country Status (19)

Country Link
JP (1) JPS5242840A (forum.php)
AT (1) AT347427B (forum.php)
AU (1) AU503212B2 (forum.php)
BE (1) BE846837A (forum.php)
CS (2) CS199644B2 (forum.php)
DD (1) DD126278A5 (forum.php)
DE (1) DE2640972A1 (forum.php)
DK (1) DK141622B (forum.php)
ES (1) ES451979A1 (forum.php)
FI (1) FI762660A7 (forum.php)
FR (1) FR2326183A1 (forum.php)
GB (1) GB1542317A (forum.php)
LU (1) LU75916A1 (forum.php)
NL (1) NL7610845A (forum.php)
NO (1) NO763345L (forum.php)
NZ (1) NZ182165A (forum.php)
SE (1) SE7510988L (forum.php)
SU (2) SU638252A3 (forum.php)
ZA (1) ZA765331B (forum.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1273A (en) 1980-07-09 1985-03-08 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
SK282225B6 (sk) * 1995-12-28 2001-12-03 Welfide Corporation Použitie 2-amino-2[2-(4-oktylfenyl)etyl]-propán-1,3-diolu alebo jeho farmaceuticky prijateľnej adičnej soli s kyselinou na výrobu farmaceutického prostriedku
AU2004267016B2 (en) 2003-06-17 2011-11-24 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
CN103189359A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的光学活性酸盐
KR20180094131A (ko) 2010-09-01 2018-08-22 에자이 알앤드디 매니지먼트 가부시키가이샤 신장 손상을 갖는 개체에 대한 로카세린의 투여
CA2886875A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
GB1542317A (en) 1979-03-14
SU674669A3 (ru) 1979-07-15
NL7610845A (nl) 1977-04-05
DE2640972A1 (de) 1977-04-14
ES451979A1 (es) 1978-01-01
AU1812276A (en) 1978-04-06
DK141622B (da) 1980-05-12
FR2326183A1 (fr) 1977-04-29
AU503212B2 (en) 1979-08-30
BE846837A (fr) 1977-04-01
SU638252A3 (ru) 1978-12-15
CS199643B2 (en) 1980-07-31
FI762660A7 (forum.php) 1977-04-02
AT347427B (de) 1978-12-27
SE7510988L (sv) 1977-04-02
ATA682376A (de) 1978-05-15
NZ182165A (en) 1978-07-10
DD126278A5 (forum.php) 1977-07-06
DK439776A (forum.php) 1977-04-02
NO763345L (forum.php) 1977-04-04
LU75916A1 (forum.php) 1978-05-16
CS199644B2 (en) 1980-07-31
JPS5242840A (en) 1977-04-04

Similar Documents

Publication Publication Date Title
JPS51131843A (en) Lipidddepleted active compound
ZA776129B (en) Pharmaceutically active compounds
ZA763652B (en) Pharmacologically active compounds
MW3476A1 (en) Pharmacologically active compounds
ZA767198B (en) Pharmacologically active compounds
PT67046A (en) Pharmacologically active compounds
ZA764082B (en) Pharmacologically active compounds
JPS5228945A (en) Pharmaceutically active ooacyll 2*33diaryll33halogenn acrylaldoxim
ZA765331B (en) Novel pharmaceutically active compounds
ZA7682B (en) Pharmacologically active compounds
ZM9676A1 (en) Pharmacologically active compounds
PT66255A (en) Pharmacologically active compounds
ZA761324B (en) Pharmaceutically active compounds
ZM9776A1 (en) Pharmacologically active compounds
ZA762536B (en) Pharmacologically active compounds
ZA766778B (en) Pharmacologically active compounds
ZA774220B (en) Pharmacologically active compounds
GB1487036A (en) Pharmaceutically useful 2-aminoacetoamido-alpha-phenylbenzylideneaminoalkanol derivatives
GB1483448A (en) Therapeutically active basic ethers
ZA766201B (en) Pharmacologically active compounds
JPS5283745A (en) Pharmaceutically active compound
AU1059176A (en) Pharmacologically active compositions
ZA764183B (en) Pharmaceutically active peptides
MW2876A1 (en) Pharmacologically active compounds
MW2776A1 (en) Pharmacologically active compounds